iShares Global Clean Energy ETF (ICLN) Stock Price Today
Aura AI Summary
Key Stats
- -MARKET_CAP
- -VOLUME
- -SECTOR
- $23.75FIFTY_TWO_WEEK_HIGH
- $13.37FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- -ENTERPRISE_VALUE
- -DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track iShares Global Clean Energy ETF (ICLN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, iShares Global Clean Energy ETF has traded between a low of $13.37 and a high of $23.75, highlighting its annual price range. Buy and sell iShares Global Clean Energy ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Most Recent News
Wall Street rises as Fed rate cut hopes grow despite weak jobs data
Wall Street ended the holiday-shortened week higher, driven by optimism over a potential Federal Reserve interest rate cut by year-end despite weaker-than-expected June jobs data. Technology stocks rebounded early in the week amid easing U.S.-Iran te...

Tariff uncertainty fuels volatility as Dow eyes 55,000 and S&P 500 targets 8,000.
The US stock market shows resilience amid tariff uncertainties and mixed labor data. The Dow Jones benefits from a rotation into value and cyclical stocks, supporting a bullish outlook toward 55,000. Meanwhile, the S&P 500 faces pressure from weak me...

Imugene reports second complete response in Phase 1b trial for aggressive lymphoma treatment
Imugene Ltd announced a second complete response in its Phase 1b azer-cel trial targeting patients with mantle cell lymphoma (MCL) who had failed prior BTKi therapy. The patient showed complete tumor shrinkage by Day 28, earlier than expected, highli...
